Cargando…

Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare prognostic value of 7 available tools (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in patients aged <50...

Descripción completa

Detalles Bibliográficos
Autores principales: Jara-Palomares, Luis, Alfonso, Maria, Maestre, Ana, Jimenez, David, Garcia-Bragado, Fernando, Font, Carme, Reyes, Raquel Lopez, Blasco, Luis Hernandez, Vidal, Gemma, Otero, Remedios, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934558/
https://www.ncbi.nlm.nih.gov/pubmed/31882805
http://dx.doi.org/10.1038/s41598-019-55213-8
_version_ 1783483410749063168
author Jara-Palomares, Luis
Alfonso, Maria
Maestre, Ana
Jimenez, David
Garcia-Bragado, Fernando
Font, Carme
Reyes, Raquel Lopez
Blasco, Luis Hernandez
Vidal, Gemma
Otero, Remedios
Monreal, Manuel
author_facet Jara-Palomares, Luis
Alfonso, Maria
Maestre, Ana
Jimenez, David
Garcia-Bragado, Fernando
Font, Carme
Reyes, Raquel Lopez
Blasco, Luis Hernandez
Vidal, Gemma
Otero, Remedios
Monreal, Manuel
author_sort Jara-Palomares, Luis
collection PubMed
description In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare prognostic value of 7 available tools (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in patients aged <50 years. We used the RIETE database, including PE patients from 2001 to 2017. The major outcome was 30-day all-cause mortality. Of 34,651 patients with acute PE, 5,822 (17%) were aged <50 years. Of these, 83 (1.4%) died during the first 30 days. Number of patients deemed low risk with tools was: PREP (95.9%), GPS (89.6%), PESI (87.2%), Shock index (70.9%), sPESI (59.4%), Prognostic algorithm (58%) and RIETE score (48.6%). The tools with a highest sensitivity were: Prognostic Algorithm (91.6%; 95% CI: 85.6–97.5), RIETE score (90.4%; 95%CI: 84.0–96.7) and sPESI (88%; 95% CI: 81–95). The RIETE, Prognostic Algorithm and sPESI scores obtained the highest overall sensitivity estimates for also predicting 7- and 90-day all-cause mortality, 30-day PE-related mortality, 30-day major bleeding and 30-day VTE recurrences. The proportion of low-risk patients who died within the first 30 days was lowest using the Prognostic Algorithm (0.2%), RIETE (0.3%) or sPESI (0.3%) scores. In PE patients less 50 years, 30-day mortality was low. Although sPESI, RIETE and Prognostic Algorithm scores were the most sensitive tools to identify patients at low risk to die, other tools should be evaluated in this population to obtain more efficient results.
format Online
Article
Text
id pubmed-6934558
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69345582019-12-29 Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years Jara-Palomares, Luis Alfonso, Maria Maestre, Ana Jimenez, David Garcia-Bragado, Fernando Font, Carme Reyes, Raquel Lopez Blasco, Luis Hernandez Vidal, Gemma Otero, Remedios Monreal, Manuel Sci Rep Article In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare prognostic value of 7 available tools (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in patients aged <50 years. We used the RIETE database, including PE patients from 2001 to 2017. The major outcome was 30-day all-cause mortality. Of 34,651 patients with acute PE, 5,822 (17%) were aged <50 years. Of these, 83 (1.4%) died during the first 30 days. Number of patients deemed low risk with tools was: PREP (95.9%), GPS (89.6%), PESI (87.2%), Shock index (70.9%), sPESI (59.4%), Prognostic algorithm (58%) and RIETE score (48.6%). The tools with a highest sensitivity were: Prognostic Algorithm (91.6%; 95% CI: 85.6–97.5), RIETE score (90.4%; 95%CI: 84.0–96.7) and sPESI (88%; 95% CI: 81–95). The RIETE, Prognostic Algorithm and sPESI scores obtained the highest overall sensitivity estimates for also predicting 7- and 90-day all-cause mortality, 30-day PE-related mortality, 30-day major bleeding and 30-day VTE recurrences. The proportion of low-risk patients who died within the first 30 days was lowest using the Prognostic Algorithm (0.2%), RIETE (0.3%) or sPESI (0.3%) scores. In PE patients less 50 years, 30-day mortality was low. Although sPESI, RIETE and Prognostic Algorithm scores were the most sensitive tools to identify patients at low risk to die, other tools should be evaluated in this population to obtain more efficient results. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934558/ /pubmed/31882805 http://dx.doi.org/10.1038/s41598-019-55213-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jara-Palomares, Luis
Alfonso, Maria
Maestre, Ana
Jimenez, David
Garcia-Bragado, Fernando
Font, Carme
Reyes, Raquel Lopez
Blasco, Luis Hernandez
Vidal, Gemma
Otero, Remedios
Monreal, Manuel
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title_full Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title_fullStr Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title_full_unstemmed Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title_short Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
title_sort comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934558/
https://www.ncbi.nlm.nih.gov/pubmed/31882805
http://dx.doi.org/10.1038/s41598-019-55213-8
work_keys_str_mv AT jarapalomaresluis comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT alfonsomaria comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT maestreana comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT jimenezdavid comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT garciabragadofernando comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT fontcarme comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT reyesraquellopez comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT blascoluishernandez comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT vidalgemma comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT oteroremedios comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT monrealmanuel comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years
AT comparisonofsevenprognostictoolstoidentifylowriskpulmonaryembolisminpatientsaged50years